CLU and metabolic dysfunction-associated steatotic liver disease: In agreement with the results that CHC patients exhibited clinical manifestations similar to those in the overweight-induced progression of NAFLD4, the present study suggested that CHC or NAFLD patients might have a similar regulatory scenario in which circulating ApoJ correlated positively with TC and LDL (Fig. 6).